rcherqi@gmail.com
-
Communication and society involvement
Risk Factors of COVID-19 Patients
https://www.cambridge.org/core/journals/disaster-medicine-and-public-health-preparedness/article/risk-factors-of-covid19-patients/B80BD023C7188E805711875A43F52CF2#
-
Health care
COVID-19 Cancer Recommendation Consequences on One Radiation Therapy Department Economics and Employee Working Conditions’ Satisfaction in France
COVID-19 Cancer Recommendation Consequences on One Radiation Therapy Department Economics and Employee Working Conditions’ Satisfaction in France
-
Communication and society involvement
Covid-19 : au Royaume-Uni, une mutation interroge
https://www.lepoint.fr/monde/covid-19-au-royaume-uni-une-mutation-interroge-14-12-2020-2405750_24.php
-
Communication and society involvement
Covid-19: une mutation du virus très surveillée.
https://www.lefigaro.fr/sciences/covid-19-une-mutation-du-virus-tres-surveillee-20201127
-
Communication and society involvement
Une mutation du nouveau coronavirus inquiète le Royaume-Uni
https://www.nouvelobs.com/coronavirus-de-wuhan/20201214.OBS37540/une-mutation-du-nouveau-coronavirus-inquiete-le-royaume-uni.html
-
Communication and society involvement
Personnalisation de la prise en charge nutritionnelle du patient COVID-19 = Personalization of the nutritional case of the COVID-19 patient
PERSONNALISATION DE LA PRISE EN CHARGE NUTRITIONNELLE DU PATIENT COVID-19
-
Communication and society involvement
Incidence et mortalité du COVID19 en Afrique = COVID19 incidence and mortality in Africa
Incidence et mortalité du COVID19 en Afrique
-
Communication and society involvement
Bidirectional associations between COVID-19 and psychiatric disorder: retrospective cohort studies of 62 354 COVID-19 cases in the USA
Bidirectional associations between COVID-19 and psychiatric disorder
-
Communication and society involvement
Effect of an Inactivated Vaccine Against SARS-CoV-2 on Safety and Immunogenicity Outcomes: Interim Analysis of 2 Randomized Clinical Trials
Effect of an Inactivated Vaccine Against SARS-CoV-2 on Safety and immunogenicity and outcomes